Recombinant BCG vaccines reduce pneumovirus-caused airway pathology by inducing protective humoral immunity

dc.creatorSoto, Jorge A.
dc.creatorGálvez Arriagada, Nicolás Marcelo Salvador
dc.creatorRivera, Claudia A.
dc.creatorPalavecino, Christian E.
dc.creatorCespedes, Pablo F.
dc.creatorRey Jurado, Emma
dc.creatorBueno Ramírez, Susan
dc.creatorKalergis Parra, Alexis Mikes
dc.date.accessioned2020-09-01T21:25:59Z
dc.date.available2020-09-01T21:25:59Z
dc.date.created2020-09-01T21:25:59Z
dc.date.issued2018
dc.identifier10.3389/fimmu.2018.02875
dc.identifier1664-3224
dc.identifierhttps://doi.org/10.3389/fimmu.2018.02875
dc.identifierhttps://repositorio.uc.cl/handle/11534/43254
dc.languageen
dc.rightsacceso abierto
dc.subjectHRSV
dc.subjectHMPV
dc.subjectAntibodies
dc.subjectHumoral immune response
dc.subjectVaccine
dc.subjectRespiratory virus
dc.subjectBCG
dc.titleRecombinant BCG vaccines reduce pneumovirus-caused airway pathology by inducing protective humoral immunity
dc.typeartículo


Este ítem pertenece a la siguiente institución